148 related articles for article (PubMed ID: 17350957)
21. RAP80 interacts with the SUMO-conjugating enzyme UBC9 and is a novel target for sumoylation.
Yan J; Yang XP; Kim YS; Joo JH; Jetten AM
Biochem Biophys Res Commun; 2007 Oct; 362(1):132-138. PubMed ID: 17698038
[TBL] [Abstract][Full Text] [Related]
22. Interaction of moloney murine leukemia virus capsid with Ubc9 and PIASy mediates SUMO-1 addition required early in infection.
Yueh A; Leung J; Bhattacharyya S; Perrone LA; de los Santos K; Pu SY; Goff SP
J Virol; 2006 Jan; 80(1):342-52. PubMed ID: 16352559
[TBL] [Abstract][Full Text] [Related]
23. Smt3/SUMO and Ubc9 are required for efficient APC/C-mediated proteolysis in budding yeast.
Dieckhoff P; Bolte M; Sancak Y; Braus GH; Irniger S
Mol Microbiol; 2004 Mar; 51(5):1375-87. PubMed ID: 14982631
[TBL] [Abstract][Full Text] [Related]
24. Noncovalent interaction between Ubc9 and SUMO promotes SUMO chain formation.
Knipscheer P; van Dijk WJ; Olsen JV; Mann M; Sixma TK
EMBO J; 2007 Jun; 26(11):2797-807. PubMed ID: 17491593
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of the interactions of HIV-1 integrase with small ubiquitin-like modifiers and their conjugation enzyme Ubc9.
Li Z; Wu S; Wang J; Li W; Lin Y; Ji C; Xue J; Chen J
Int J Mol Med; 2012 Nov; 30(5):1053-60. PubMed ID: 22895527
[TBL] [Abstract][Full Text] [Related]
26. HMGA1-pseudogenes and cancer.
De Martino M; Forzati F; Arra C; Fusco A; Esposito F
Oncotarget; 2016 May; 7(19):28724-35. PubMed ID: 26895108
[TBL] [Abstract][Full Text] [Related]
27. Two new miR-16 targets: caprin-1 and HMGA1, proteins implicated in cell proliferation.
Kaddar T; Rouault JP; Chien WW; Chebel A; Gadoux M; Salles G; Ffrench M; Magaud JP
Biol Cell; 2009 Sep; 101(9):511-24. PubMed ID: 19250063
[TBL] [Abstract][Full Text] [Related]
28. Dnmt3b, de novo DNA methyltransferase, interacts with SUMO-1 and Ubc9 through its N-terminal region and is subject to modification by SUMO-1.
Kang ES; Park CW; Chung JH
Biochem Biophys Res Commun; 2001 Dec; 289(4):862-8. PubMed ID: 11735126
[TBL] [Abstract][Full Text] [Related]
29. Identification of a molecular recognition feature in the E1A oncoprotein that binds the SUMO conjugase UBC9 and likely interferes with polySUMOylation.
Yousef AF; Fonseca GJ; Pelka P; Ablack JN; Walsh C; Dick FA; Bazett-Jones DP; Shaw GS; Mymryk JS
Oncogene; 2010 Aug; 29(33):4693-704. PubMed ID: 20543865
[TBL] [Abstract][Full Text] [Related]
30. The type 2 dengue virus envelope protein interacts with small ubiquitin-like modifier-1 (SUMO-1) conjugating enzyme 9 (Ubc9).
Chiu MW; Shih HM; Yang TH; Yang YL
J Biomed Sci; 2007 May; 14(3):429-44. PubMed ID: 17265167
[TBL] [Abstract][Full Text] [Related]
31. SUMO Ubc9 enzyme as a viral target.
Varadaraj A; Mattoscio D; Chiocca S
IUBMB Life; 2014 Jan; 66(1):27-33. PubMed ID: 24395713
[TBL] [Abstract][Full Text] [Related]
32. The high-mobility group A1a/signal transducer and activator of transcription-3 axis: an achilles heel for hematopoietic malignancies?
Hillion J; Dhara S; Sumter TF; Mukherjee M; Di Cello F; Belton A; Turkson J; Jaganathan S; Cheng L; Ye Z; Jove R; Aplan P; Lin YW; Wertzler K; Reeves R; Elbahlouh O; Kowalski J; Bhattacharya R; Resar LM
Cancer Res; 2008 Dec; 68(24):10121-7. PubMed ID: 19074878
[TBL] [Abstract][Full Text] [Related]
33. Purification and activity assays for Ubc9, the ubiquitin-conjugating enzyme for the small ubiquitin-like modifier SUMO.
Yunus AA; Lima CD
Methods Enzymol; 2005; 398():74-87. PubMed ID: 16275321
[TBL] [Abstract][Full Text] [Related]
34. Ubc9 promotes the stability of Smad4 and the nuclear accumulation of Smad1 in osteoblast-like Saos-2 cells.
Shimada K; Suzuki N; Ono Y; Tanaka K; Maeno M; Ito K
Bone; 2008 May; 42(5):886-93. PubMed ID: 18321803
[TBL] [Abstract][Full Text] [Related]
35. A non-covalent interaction between small ubiquitin-like modifier-1 and Zac1 regulates Zac1 cellular functions.
Liu ST; Chang YL; Wang WM; Chung MH; Lin WS; Chou WY; Huang SM
Int J Biochem Cell Biol; 2012 Mar; 44(3):547-55. PubMed ID: 22227369
[TBL] [Abstract][Full Text] [Related]
36. A functional interaction between RHA and Ubc9, an E2-like enzyme specific for Sumo-1.
Argasinska J; Zhou K; Donnelly RJ; Hay RT; Lee CG
J Mol Biol; 2004 Jul; 341(1):15-25. PubMed ID: 15312759
[TBL] [Abstract][Full Text] [Related]
37. Ubc9 fusion-directed SUMOylation (UFDS): a method to analyze function of protein SUMOylation.
Jakobs A; Koehnke J; Himstedt F; Funk M; Korn B; Gaestel M; Niedenthal R
Nat Methods; 2007 Mar; 4(3):245-50. PubMed ID: 17277783
[TBL] [Abstract][Full Text] [Related]
38. An extended consensus motif enhances the specificity of substrate modification by SUMO.
Yang SH; Galanis A; Witty J; Sharrocks AD
EMBO J; 2006 Nov; 25(21):5083-93. PubMed ID: 17036045
[TBL] [Abstract][Full Text] [Related]
39. Role of an N-terminal site of Ubc9 in SUMO-1, -2, and -3 binding and conjugation.
Tatham MH; Kim S; Yu B; Jaffray E; Song J; Zheng J; Rodriguez MS; Hay RT; Chen Y
Biochemistry; 2003 Aug; 42(33):9959-69. PubMed ID: 12924945
[TBL] [Abstract][Full Text] [Related]
40. SUMO and SUMO-Conjugating Enzyme E2 UBC9 Are Involved in White Spot Syndrome Virus Infection in Fenneropenaeus chinensis.
Tang X; Li W; Xing J; Sheng X; Zhan W
PLoS One; 2016; 11(2):e0150324. PubMed ID: 26927328
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
